北京乔治医学研究有限公司

The George Institute for Global Health The George Institute for Global Health was established in 1999 as an independent not-for-profit organisation dedicated to the prevention and management of non-communicable diseases and injury, through domestic and international programs. The George Institute has grown rapidly since its inception, and currently employs approximately 350 people globally with 200 staff located at its headquarters in Sydney. The George Institute manages numerous large-scale international and regional trials and projects funded by a diverse range of sponsors, both public and private. The research portfolio of the institute includes randomized trials of new treatment and prevention strategies, surveys, and observational studies of the causes and outcomes of disease and injury. The current research budget of the Institute is approximately $25-30 million per year. Research revenue comes from national and international medical research agencies, private sponsors and industry. Clinical research trials and operations are conducted at approximately 600 centres in more than 30 countries worldwide. While Asia is a major focus, the George Institute is also active throughout Europe, North America, and Australasia. The George Institute has offices in Sydney, Hyderabad, London and Beijing. The George Institute also provides strategic consulting and operational services to external clients in the biotechnology and pharmaceutical industries. The George Institute is dedicated to the recruitment, development, and retention of the best people from around the world. The pursuit of academic, scientific and operational excellence in a “can do” culture is actively promoted in all our activities. Context The Goerge Institute for Global Health, China (GIC) aims to facilitate the sharing of knowledge, information and ideas, and skills across all areas of clinical research, training, teaching, clinical practice, and policy development with our partners in China. The ultimate goal is a sustained commitment to the implementation of evidence-based policy and practice that addresses the burden of disease. Diabetes Research (DR) is a new erected section in GIC. The key role of DR team is to support the development and implementation of high quality projects / initiatives in diabetes in China. The team member will participate in all phases of project development, providing advice on concept development, project management structures, logistics, capacity development activities, potential funding sources, media relations, and strategies for the dissemination of research findings to facilitate uptake into practice. Studies cover the area of epidemiology, prevention, health care and management, treatment and health economy on diabetes. In collaboration with IDF (International Diabetes Federation) and CDS (Chinese Diabetes Society), several large-scale investigation projects have been launched to assess the incidence, care, treatment and cost of diabetes mellitus in China. Hundreds of health care facilities have been covered in these studies. Talents have academic study background are welcome to join the team.